Citation:Kudoh S, Takeda K, Nakagawa K, Takada M, Katakami N, Matsui K, et al 2006

From Cancer Guidelines Wiki

Citation


Kudoh S, Takeda K, Nakagawa K, Takada M, Katakami N, Matsui K, et al. Phase III study of docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer: results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904). J Clin Oncol 2006 Aug 1;24(22):3657-63 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/16877734.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
What is the optimal systemic therapy for stage IV inoperable NSCLC?Assoc. Prof. Nick Pavlakiscompleted
What is the optimal systemic therapy regimen for elderly patients for treatment of stage IV inoperable NSCLC?Assoc. Prof. Nick Pavlakiscompleted

Compare quality appraisals for each clinical question

Cited by

  1. What is the optimal systemic therapy for stage IV inoperable NSCLC?
  2. What is the optimal systemic therapy regimen for elderly patients for treatment of stage IV inoperable NSCLC?